Topics

Gliomas | Treatment | Targeted therapy | IDH inhibitors

Home > Publications > Topics > Gliomas > Treatment > Targeted therapy > IDH inhibitors

Ser MH, Webb M, Thomsen A, Sener U.
Isocitrate Dehydrogenase Inhibitors in Glioma: From Bench to Bedside.
Pharmaceuticals (Basel). 2024 May 26;17(6):682. doi: 10.3390/ph17060682. PMID: 38931350. Review. ˍ

van den Bent MJ, French PJ, Brat D, Tonn JC, Touat M, Ellingson BM, Young RJ, Pallud J, von Deimling A, Sahm F, Figarella Branger D, Huang RY, Weller M, Mellinghoff IK, Cloughsey TF, Huse JT, Aldape K, Reifenberger G, Youssef G, Karschnia P, Noushmehr H, Peters KB, Ducray F, Preusser M, Wen PY.
The biological significance of tumor grade, age, enhancement and extent of resection in IDH mutant gliomas: how should they inform treatment decision in the era of IDH inhibitors? Invited review.
Neuro Oncol. 2024 Jun 24:noae107. doi: 10.1093/neuonc/noae107. PMID: 38912846. Review. ˍ

Still MEH, Moor RSF, Ghiaseddin AP, Leibetseder A, Hottinger AF, Berghoff A, Leung D.
How do I prescribe and manage mIDH inhibitors in patients with IDH-mutant glioma?
Neurooncol Pract. 2024 Dec 3;12(Suppl 1):i19-i25. doi: 10.1093/nop/npae112. PMID: 39776526. Review. ˍ

Roth P, Capper D, Calabrese E, Halasz LM, Jakola AS.
Role of the tumor board when prescribing mutant isocitrate dehydrogenase inhibitors to patients with isocitrate dehydrogenase-mutant glioma.
Neurooncol Pract. 2024 Dec 4;12(Suppl 1):i29-i37. doi: 10.1093/nop/npae100. PMID: 39776528. Review. ˍ

Drummond KJ, Spiteri M, Cain SA, Jones J, Shaya S, Topp M, Lu T, Tobler R, Valkovic AL, Moore Z, Fatunla OE, Kriel J, Moffet JJD, McAlpine H, Rosier M, Guan H, Dimou J, Schadewaldt V, Roberts-Thomson S, McArdle D, Lui E, Voelker-Albert M, di Sanzo S, Nijagal B, Narayana VK, Mitchell CB, Vissers JHA, Grimmond S, Rosenthal MA, Palmer LM, Best SA, Freytag S, Whittle JR.
Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial.
Nat Med. 2025 Aug 21. doi: 10.1038/s41591-025-03884-4. PMID: 40841487. Interventional study. ˍ ClinicalTrials.gov ID: NCT05577416.